Weight stigma and allostatic load in adults: protocol for a scoping review.

INTRODUCTION: Weight-related stigma (WS) has been associated with adverse psychosocial and physical health effects. Despite the relationship between WS and allostatic load, there are no integrative reviews of this association. This scoping review aims to provide a comprehensive overview of the relationship between allostatic load biomarkers associated with WS by identifying gaps in this topic and proposing recommendations for future research. METHODS AND ANALYSIS: This protocol was guided by the methodological framework of Arksey and O'Malley and the Joanna Briggs Institute (JBI). The research questions were based on the population-concept-context framework. Studies in adults diagnosed as overweight or obese, exposed to WS and assessing the association between WS and biomarkers of allostatic load will be included. A search will be conducted in Medline (Ovid), PsycINFO (Ovid), Scopus (Elsevier), Cochrane Library (Wiley) and Google Scholar. The search strategy will be conducted in three stages, based on the JBI recommendation with the MESH terms "Social Stigma," "Weight Prejudice," "Biomarkers," "Allostasis," "Adults" and related terms. Data extraction will be done with a template adapted from JBI. The search strategy and selection process results will be presented in a flow chart and summarised in the text. The main results will be presented in a descriptive synthesis. ETHICS AND DISSEMINATION: Ethics review and approval are not required. The results will be disseminated through peer-reviewed publications, conferences, congresses or symposia.

Knowledge about COVID-19 in the General Population of Mexico

An analytical observational study was conducted to investigate the association between knowledge of COVID-19 in the general population of Mexico and sociodemographic variables of interest. A total of 758 adults between 18 and 74 years old (M = 37.3 SD = 12.6), of which 88.9% had higher education and 33.2% were health care workers, participated in an online questionnaire assessing disease knowledge and the COVID-5 item Fear Scale, which was adapted by the research team. The proportion of individuals with high knowledge about COVID-19 was found to be 41.0%. Participants with higher education and healthcare professionals demonstrated higher knowledge scores in comparison to those with primary and secondary education, as well as non-healthcare professionals (PR=1.25, 95%CI 1.05-1.48). In conclusion, that people with higher education and healthcare workers exhibited better knowledge scores regarding the disease, while high knowledge about COVID-19 was only associated with being a health professional.

Se realizó un estudio observacional analítico con el objetivo de explorar la asociación entre el conocimiento que tiene la población general de México sobre COVID-19 y las variables sociodemográficas de interés. Un total de 758 adultos entre 18 y 74 años (M=37,3 DE=12,6), 88,9% con educación superior y 33,2% trabajadores de la salud, diligenciaron un cuestionario en línea sobre conocimientos la enfermedad y la Escala de Temor a COVID-5, adaptada por el equipo de investigación. La proporción de conocimientos altos sobre COVID-19 fue del 41,0%. Las personas con educación superior y los profesionales de la salud presentaron puntajes de conocimientos altos en comparación con los que tenían primaria y secundaria y con los que no pertenecían al gremio de la salud RP = 1,25 IC 95% (1,05 - 1,48). Se concluye que las personas con escolaridad superior y los profesionales de la salud tienen mejores puntajes de conocimientos sobre la enfermedad, mientras que el conocimiento alto sobre COVID-19 solo se asoció con ser profesional de la salud.

Foi realizado um estudo observacional analítico com o objetivo de explorar a associação entre o conhecimento que tem a população geral de México sobre COVID-19 e as variáveis sociodemográficas de interesse. Um total de 758 adultos entre 18 e 74 anos (M=37,3 DE=12,6), 88,9% com ensino superior e 33,2% trabalhadores da saúde, responderam um questionário on-line sobre conhecimentos a doença e a Escala de Temor a COVID-5, adaptada pela equipe de pesquisa. A proporção de conhecimentos altos sobre COVID-19 foi do 41,0%. As pessoas com educação superior e os profissionais da saúde apresentaram pontuação de conhecimentos altos em comparação com os que tinham ensino básico e ensino médio e com os que não pertenciam aos profissionais da saúde RP = 1,25 IC 95% (1,05 - 1,48). Concluise que as pessoas com educação superior e os profissionais da saúde têm melhor pontuação de conhecimentos sobre a doença, enquanto que o conhecimento alto sobre COVID-19 só se associou com ser professional da saúde.

Confirmatory Factor Analysis, Internal Consistency, Gender Differential Item Functioning and Discriminant Validity of the Fear of COVID-5 Scale Amidst Emerging Adult University Students in Mexico.

The study aimed to perform confirmatory factor analysis, internal consistency, gender differential item functioning, and discriminant validity of the Fear of COVID-5 Scale in emerging adult students of a university in Mexico. Confirmatory factor analysis, internal consistency (Cronbach's alpha and McDonald's omega), and gender differential item functioning were estimated (Kendall tau b correlation). The Fear of COVID-5 Scale showed a one-dimension structure (RMSEA = 0.07, CFI = 0.98, TLI = 0.96, and SRMR = 0.02), with high internal consistency (Cronbach's alpha of 0.78 and McDonald's omega of 0.81), non-gender differential item functioning (Kendall tau b between 0.07 and 0.10), and significant discriminant validity (Higher scores for fear of COVID-19 were observed in high clinical anxiety levels). In conclusion, the Fear of COVID-5 Scale presents a clear one-dimension structure similar to a previous study.

Factors Associated with Cyberbullying Victimisation among Colombian High-School Adolescents.

The study's purpose was to examine the prevalence and explore some factors associated with cyberbullying in high-school adolescents at ​​Santa Marta, Colombia. A cross-sectional study was designed, which participated in students between 13 and 17 years. Participants completed the item for being a victim of cyberbullying of the Youth Risk Behavior Survey for high school students designed by the Center for Disease Control of the United States. A total of 1462 students answered the questionnaire (M = 14.4 years, SD = 0.8). 19.6% (n = 287) reported lifetime cyberbullying victimisation. Cyberbullying victimisation was associated with post-traumatic stress disorder risk (OR = 2.05, 95%CI 1.51-2.79), lifetime cigarette smoking (OR = 1.91, 95%CI 1.42-2.57), female gender (OR = 1.68, 95%CI 1.25-2.26), family dysfunction (OR = 1.68, 95%CI 1.18-2.41), and poor-fair health condition (OR = 1.45, 95%CI 1.08-1.95). Being a victim of cyberbullying is frequent among Colombian high-school adolescents. It is associated with post-traumatic stress disorder risk, cigarette smoking, female gender, family dysfunction, and poor-fair general health condition. Longitudinal investigations are needed to measure better the dynamics of cyberbullying and the nature of such associations.

Psychometric Properties of an Instrument to Assess the Fear of COVID-19 in a Sample in Argentina: a Mixed Approach.

The FCV-19S was the first instrument designed to assess the severity of fear related to COVID-19 and has already been validated in many languages. The objective of this study was to evaluate the homogeneity and construct validity of the 5-item version of the FCV19S, using an online questionnaire in 599 people. The participants' age ranged from 18 to 65 years. Age, gender, marital status, educational level, employment status, and socioeconomic status were analyzed. In the evaluation process we assessed interitem correlation, item rest-correlation, confirmatory factor analysis: Root Mean Square Error of Approximation, Comparative Fix Index, Tucker-Lewis Index; internal consistency (Cronbach's alpha, McDonald's omega), and the Rasch model was assessed for learning more about the psychometric properties of the scale, which allows a detailed knowledge of the strengths and weaknesses of a scale. The FCV-5S has adequate psychometric indicators from the perspective of the Classical Theory of Items. The major limitations were using a self-reported measure and having a convenience sample not necessarily representative of the general population of Argentina.

Adaptation and psychometric evaluation of the Fear of COVID-19 Scale in the general Colombian population.

The study aimed to adapt and explore the psychometric performance of the Fear of COVID-19 Scale (FCV-19S) in the general Colombian population. The original FCV-19S is a 7-item scale that underwent an adaptation (Item 1 and 5 were deleted). From an online sample of 1,687 adults (59% female), exploratory and confirmatory factor analyses were performed for versions of the scale with 6 and 5 items. Cronbach's alpha and McDonald's omega were calculated. The confirmatory factor analysis showed that the 5-item scale (Fear of COVID-5) presented better indicators. In conclusion, the Fear of COVID-5 has acceptable performance in the Colombian population.

Validity of the Hospital Anxiety and Depression Scale (HADS) in primary care patients in Colombia.

OBJECTIVE: To assess the validity of the Hospital Anxiety and Depression Scale (HADS) for depression and anxiety screening in primary care patients in Colombia. METHODS: A criterion validity study was conducted with 243 adults that had completed the HADS and were later assessed using the MINI as a gold standard. Cronbach's alpha, McDonald's omega and factor structure were applied through confirmatory factor analysis (CFA). ROC curve analysis and Youden's statistic were used to determine the cut-off point. RESULTS: Cronbach's α was reported to be 0.85 and 0.82 for McDonalds' ω. CFA supported a two-factor solution demonstrating satisfactory fit. Root mean square error of approximation = 0.04, Comparative Fix Index (CFI) and Tucker-Lewis Index (TLI) = 0.97. For HADS-A, the cut-off point was determined as 6 associated with a sensitivity of 0.76, a specificity of 0.72 and Youden's index of 0.50. The ABC was 0.81. For HADS-D, the cut-off point was determined as 4 associated with a sensitivity of 0.78, a specificity of 0.74 and Youden's index of 0.53. The ABC was 0.82. CONCLUSION: The HADS is a valid and reliable instrument for anxiety and depression screening in adult patients of primary healthcare services in Colombia.

Validity of the Patient Health Questionnaire-9 (PHQ-9) for depression screening in adult primary care users in Bucaramanga, Colombia. / Validez del Cuestionario de salud del paciente-9 (PHQ-9) para cribado de depresión en adultos usuarios de Atención Primaria en Bucaramanga, Colombia.

The patient health questionnaire-9 (PHQ-9) is one of the most widely used self-report instruments in primary care. There is no criterion validity of the PHQ-9 in Colombia. The objective was to validate the PHQ-9 as a screening tool in primary care. A cross-sectional, scale criterion validity study was performed using as reference criterion the mini neuropsychiatric interview (MINI) in male and female adult users of primary care centres. We calculated the internal consistency and convergent and criterion validity of the PHQ-9 by analysing the receiver operating characteristics (ROC) and the area under the curve (AUC). We analysed 243 participants; 184 (75.7%) were female. The average age was 34.05 (median of 31 and SD = 12.47). Cronbach's α was 0.80 and McDonald's ω was 0.81. Spearman's Rho was 0.64 for HADS-D (P <0.010) and 0.70 for PHQ-2 (P <0.010). The AUC was 0.92 (95% CI 0.880-0.963). The optimal cut-off point of PHQ-9 was ≥7: sensitivity of 90.38 (95% CI: 81.41-99.36); specificity of 81.68 (95% CI: 75.93-87.42); PPV 57.32 (95% CI: 46.00-68.63); NPV 96.89 (95% CI: 93.90-99.88); Youden index 0.72 (95% CI: 0.62-0.82); LR+ 4.93 (95% CI: 3.61-6.74); LR- 0.12 (95% CI: 0.005-0.270). In sum, the Colombian version of PHQ-9 is a valid and reliable instrument for depression screening in primary care in Bucaramanga, with a cut-off point ≥7.

Validez del Cuestionario de salud del paciente-9 (PHQ-9) para cribado de depresión en adultos usuarios de Atención Primaria en Bucaramanga, Colombia / Validity of the Patient Health Questionnaire-9 (PHQ-9) for depression screening in adult primary care users in Bucaramanga, Colombia

RESUMEN El Cuestionario de salud del paciente-9 (PHQ-9) es uno de los instrumentos de autoinforme más utilizado en Atención Primaria (AP). No existe validez de criterio del PHQ-9 en Colombia. El objetivo fue realizar la validez de criterio del PHQ-9 como instrumento de cribado en AP. Se realizó un estudio trasversal de validez de criterio de una escala usando como criterio de referencia la minientrevista neuropsiquiátrica (MINI) en usuarios adultos de centros de AP de ambos sexos. Se calcularon la consistencia interna y la validez convergente y de criterio del PHQ-9 mediante el análisis de las características operativas del receptor (COR) y el área bajo la curva (ABC). Participaron 243 pacientes, 184 (75,7%) fueron de sexo femenino. El promedio de edad fue 34,05 (mediana 31 y DE = 12,47). El α de Cronbach fue 0,80 y ω de McDonald, 0,81. La rho de Spearman fue 0,64 para HADS-D (p < 0,010) y 0,70 para PHQ-2 (p < 0,010). El ABC fue 0,92 (IC del 95%, 0,880-0,963). El punto de corte óptimo del PHQ-9 fue ≥ 7: sensibilidad de 90,38 (IC del 95%: 81,41-99,36); especificidad de 81,68 (IC del 95%: 75,93-87,42); el VPP 57,32 (IC del 95%: 46,00-68,63); el VPN 96,89 (IC del 95%: 93,90-99,88); índice de Youden 0,72 (IC del 95%: 0,62-0,82; LR+ 4,93 (IC del 95%: 3,61-6,74); LR- 0,12 (IC del 95%: 0,005-0,270). En conclusión, la versión colombiana del PHQ-9 es un instrumento válido y confiable para el cribado de depresión en AP de Bucaramanga, con un punto de corte ≥ 7.

ABSTRACT The patient health questionnaire-9 (PHQ-9) is one of the most widely used self-report instruments in primary care. There is no criterion validity of the PHQ-9 in Colombia. The objective was to validate the PHQ-9 as a screening tool in primary care. A cross-sectional, scale criterion validity study was performed using as reference criterion the mini neuropsychiatric interview (MINI) in male and female adult users of primary care centres. We calculated the internal consistency and convergent and criterion validity of the PHQ-9 by analysing the receiver operating characteristics (ROC) and the area under the curve (AUC). We analysed 243 participants; 184 (75.7%) were female. The average age was 34.05 (median of 31 and SD = 12.47). Cronbach's α was 0.80 and McDonald's ω was 0.81. Spearman's Rho was 0.64 for HADS-D (P <0.010) and 0.70 for PHQ-2 (P <0.010). The AUC was 0.92 (95% CI 0.880-0.963). The optimal cut-off point of PHQ-9 was ≥7: sensitivity of 90.38 (95% CI: 81.41-99.36); specificity of 81.68 (95% CI: 75.93-87.42); PPV 57.32 (95% CI: 46.00-68.63); NPV 96.89 (95% CI: 93.90-99.88); Youden index 0.72 (95% CI: 0.62-0.82); LR+ 4.93 (95% CI: 3.61-6.74); LR- 0.12 (95% CI: 0.005-0.270). In sum, the Colombian version of PHQ-9 is a valid and reliable instrument for depression screening in primary care in Bucaramanga, with a cut-off point ≥ 7.

Stigmatisation associated with COVID-19 in the general Colombian population.

BACKGROUND: As the COVID-19 pandemic progresses, the fear of infection increases and, with it, the stigma-discrimination, which makes it an additional problem of the epidemic. However, studies about stigma associated with coronavirus are scarce worldwide. AIMS: To determine the association between stigmatisation and fear of COVID-19 in the general population of Colombia. METHOD: A cross-sectional study was carried out. A total of 1,687 adults between 18 and 76 years old (M = 36.3; SD = 12.5), 41.1% health workers, filled out an online questionnaire on Stigma-Discrimination and the COVID-5 Fear Scale, adapted by the research team. RESULTS: The proportion of high fear of COVID-19 was 34.1%; When comparing the affirmative answers to the questionnaire on stigma-discrimination towards COVID-19, it was found that the difference was significantly higher in the general population compared to health workers in most of the questions evaluated, which indicates a high level of stigmatisation in that group. An association between high fear of COVID-19 and stigma was evidenced in 63.6% of the questions in the questionnaire. CONCLUSION: Stigma-discrimination towards COVID-19 is frequent in the Colombian population and is associated with high levels of fear towards said disease, mainly people who are not health workers.

Validity of the patient health questionnaire-2 (PHQ-2) for the detection of depression in primary care in Colombia.

BACKGROUND: The PHQ-2 is a screening test for major depressive disorder (MDD) derived from PHQ-9, which has shown to be useful in the detection of cases of clinical significance in previous studies. The psychometric properties of PHQ-2 in the Colombian population are unknown. METHODS: PHQ-2 were assessed in 243 patients in general medical consultations using the Mini-International Neuropsychiatric Interview (MINI) as the gold standard. Internal consistency, convergent validity and criterion validity were calculated by analyzing the Receptor Operating Characteristics (ROC) and the area under the curve (AUC). RESULTS: Cronbach's alpha and McDonald's omega coefficients were 0.71. Spearman's rho coefficients for correlations with PHQ-9 and HADS-D scores were 0.63 and 0.59 (p<0.01). AUC was 0.89. The optimal cut point was ≥2 with the following indicators: sensitivity 0.87 specificity 0.74; Youden index 0.60; PPV 0.47; NPV 0.95; (LR+) 3.24; (LR-) 0.18 (95% CI 0.09-0.37). Kappa coefficient between PHQ-2 and MINI for depression was .458 and 0.46 for HADS-D. LIMITATIONS: Since this study was done with people attending hospital, which could has implications for the prevalence of depression, affecting the validity indicators of the instrument. CONCLUSIONS: PHQ-2 show an acceptable test performance in the context of the study. However, the test could yield a considerable amount of false positives that would require specialized evaluation to establish a reliable diagnosis.

Neurocognitive disorder due to neurosyphilis: a case report. / Trastorno neurocognitivo debido a neurosífilis: informe de un caso.

INTRODUCTION: Neurosyphilis is a chronic infectious disease caused by Treponema pallidum that can cause a great variety of neuropsychiatric signs and symptoms, which complicates its diagnosis. CASE DESCRIPTION: This case occurred in a 40-year-old man who consulted the Emergency Department because of a convulsion (de novo) which was related to a chronic condition of cognitive impairment and psychosis. The appropriate studies were performed for the diagnosis of neurosyphilis and the recommended treatment was initiated. The patient presented clinical improvement and was discharged. DISCUSSION: Positive VDRL serology results and imaging findings of marked cortical atrophy conducted to consider a late-stage parenchymatous neurosyphilis with serious cognitive impairment and associated psychosis. Treatment with crystalline penicillin was formulated, which reduced the intensity of the patient's symptoms; however, the patient's lack of interest to attend the check-ups significantly reduces his chances of an adequate recovery. CONCLUSIONS: Neurosyphilis must be suspected in patients with clinically evident neurological or psychiatric symptoms. Analysis of VDRL serology and neuroimaging studies are important as an initial evaluation of the patient and must be complemented with cognitive tests or mental examination to determine the state of cognitive impairment.

Trastorno neurocognitivo debido a neurosífilis: informe de un caso / Neurocognitive disorder due to neurosyphilis: a case report

RESUMEN Introducción: La neurosífilis es una enfermedad infecciosa crónica ocasionada por Treponema pallidum y puede producir una gran variedad de signos y síntomas neuropsiquiátricos, lo que complica su diagnóstico. Descripción del caso: Se presenta el caso de un paciente de 40 años que consultó al servicio de urgencias por una convulsión de novo, junto con un cuadro crónico de deterioro cognitivo y psicosis. Se le realizaron los estudios pertinentes para el diagnóstico de neurosífilis y se inició el tratamiento recomendado. El paciente presentó mejoría clínica y fue dado de alta. Discusión: Con resultados de serología VDRL positivos y hallazgos imagenológicos de atrofia cortical marcada, se consideró una neurosífilis parenquimatosa de tipo tardío, junto con franco deterioro cognoscitivo y psicosis. Se le dejó tratamiento con penicilina cristalina, que disminuyó la intensidad de los síntomas del paciente; sin embargo, el poco interés de este en asistir a sus controles disminuye sus probabilidades de una recuperación adecuada. Conclusiones: La neurosífilis se debe sospechar en pacientes con síntomas neurológicos o psiquiátricos clínicamente evidentes. El análisis de la serología de VDRL y los estudios de neuroimagen son importantes como evaluación inicial del paciente, que debe complementarse con pruebas cognitivas o examen mental para determinar el estado de deterioro cognitivo.

ABSTRACT Introduction: Neurosyphilis is a chronic infectious disease caused by Treponema pallidum that can cause a great variety of neuropsychiatric signs and symptoms, which complicates its diagnosis. Case description: This case occurred in a 40-year-old man who consulted the Emergency Department because of a convulsion (de novo) which was related to a chronic condition of cognitive impairment and psychosis. The appropriate studies were performed for the diagnosis of neurosyphilis and the recommended treatment was initiated. The patient presented clinical improvement and was discharged. Discussion: Positive VDRL serology results and imaging findings of marked cortical atrophy conducted to consider a late-stage parenchymatous neurosyphilis with serious cognitive impairment and associated psychosis. Treatment with crystalline penicillin was formulated, which reduced the intensity of the patient's symptoms; however, the patient's lack of interest to attend the check-ups significantly reduces his chances of an adequate recovery. Conclusions: Neurosyphilis must be suspected in patients with clinically evident neurological or psychiatric symptoms. Analysis of VDRL serology and neuroimaging studies are important as an initial evaluation of the patient and must be complemented with cognitive tests or mental examination to determine the state of cognitive impairment.

Trastornos por consumo de sustancias: entre las inequidades y el estigma / Substance use disorders: Between inequities and stigma

Las personas que reúnen criterios para trastornos por consumo de sustancias (TCS) son víctimas, con frecuencia, del complejo estigma-discriminación (CED), no solo por parte de la sociedad en general, sino también por profesionales de la salud y por el autoestigma. No obstante, por la relación de los TCS con factores biológicos predisponentes y condiciones sociales adversas, se considera que estos son "autoinducidos". Asimismo, se conoce que en los TCS se presentan cambios biológicos, psicológicos o del desarrollo que menoscaban la decisión de abandono y la persistencia en el consumo, a pesar de las consecuencias negativas físicas, emocionales y sociales. El CED relacionado con el TCS es un estresor que deteriora aún más la calidad de vida de las personas consumidoras y, al mismo tiempo, se configura como una barrera de acceso a servicios de salud. Es necesario diseñar e investigar la efectividad de estrategias para reducir el CED relacionado con TCS en diferentes poblaciones y contextos.

People who meet criteria for substance use disorders (SUD) are often victims of the stigma-discrimination complex (SDC) not only by the society in general, but also by health professionals and the presence of self-stigma. However, because of the relationship of the SUD with predisposing biological factors and adverse social conditions, SUD are considered 'self-induced'. Likewise, it is known that SUD presents biological, psychological or developmental changes that undermine the decision of abandonment and persistence in consumption, despite negative physical, emotional and social consequences. The SDC related to SUD is a stressor that deteriorates the quality of life of consumers and, at the same time, it is configured as a barrier to access to health services. It is necessary to design and investigate the effectiveness of strategies to reduce SDC related to SUD in different populations and settings.

Validez de apariencia y adaptación de la escala PHQ-9 para la detección de sintomatología depresiva en universitarios de ciencias de la salud de Cartagena (Colombia) / Face validity and adaptation of the PHQ-9 for detection of depressive symptoms in university health sciences students Cartagena (Colombia)

Resumen Objetivos: Determinar la validez de apariencia del PHQ-9 para la detección de sintomatología depresiva en estudiantes de ciencias de la salud de la Universidad de Cartagena (Colombia). Materiales y métodos: Estudio transversal que evalúa el comportamiento psicométrico de la escala PHQ-9. Se consultó a 10 expertos en el área de investigación y diagnóstico clínico. Para determinar la validez de apariencia se utilizó la pertinencia y adecuación. La pertinencia se realizó a través de la tasa de validez de contenido. Para evaluar la adecuación, se realizó un grupo de discusión. Resultados: La pertinencia arrojó que todos los ítems de la escala PHQ-9 eran esenciales para evaluar la sintomatología depresiva en la población estudiada con una CVR igual a 1 en los nueve ítems evaluados (Esencial CVR ≥ 0.62, p = 0,05). Para la adecuación se realizaron los ajustes idiomáticos de todos los ítems teniendo en cuenta las observaciones relevantes de los expertos y las conclusiones del grupo de discusión. Conclusiones: El PHQ-9 mostró adecuada validez de apariencia, es necesario evaluar el desempeño psicométrico de esta versión de la escala en esta población.

Abstract Objective: To determine the appearance validity of the PHQ-9 for the detection of depressive symptoms among health sciences students at the University of Cartagena, Colombia Materials and Methods: A cross sectional study that assesses the psychometric properties of the PHQ-9 scale. It was consulted to 10 experts in the areas of research and clinical diagnosis. To determine the appearance validity, they were used the relevance and adequacy. Relevance determination was performed through rate content. To assess the adequacy, a panel discussion was conducted. Results: The relevance found that all the items of the PHQ-9 scale were essential for depressive symptoms screening in this population. With a CVR equal to 1 in the nine items evaluated (CVR Essential ≥ 0.62, p = 0.05). For adequacy, idiomatic settings of all items were made taking into account the relevant comments from experts and the panel discussion conclusions. Conclusions: the Phq-9 scale has an adequate appearance validity, it is necessary to evaluate the psychometric properties of this version of the scale in our population.

Trastornos adictivos como enfermedades del cerebro: Análisis de la evidencia e implicaciones prácticas / Addictive disorders such as brain diseases: Analysis of the evidence and practical implications

Resumen En las últimas décadas la investigación neurocientífica soporta el hecho de que las adicciones son enfermedades del cerebro, como la epilepsia o la enfermedad de Parkinson. El enfoque de manejar las adicciones de manera punitiva no ha arrojado resultados satisfactorios; por eso la investigación básica y clínica cada vez aporta más evidencia que la adicción podría ser mejor considerada y tratada como una enfermedad adquirida del cerebro, lo que constituye el "modelo de enfermedad cerebral de las adicciones". Con el desarrollo de este modelo se ha conseguido un avance significativo en la implementación de estrategias de prevención y tratamiento más efectivo, así como políticas de salud pública mejor fundamentadas. No obstante, el concepto de la adicción como una enfermedad del cerebro sigue siendo cuestionado. En este artículo se exponen argumentos para considerar los trastornos por uso de sustancias como enfermedades producidas por alteraciones en la estructura y funcionamiento de áreas específicas del cerebro, así como visualizar las implicaciones clínicas y en la política pública de éste modelo de enfermedad.

Abstract In the last decades, neuroscientific research has supported the fact that addictions are diseases of the brain such as epilepsy or Parkinson's disease. The punitive approach to manage addictions has not yielded satisfactory results, therefore the basic and clinical research provides growing evidence that addiction could be better considered and treated as an acquired brain disease which constitute the brain disease model of addictions. With the development of this model, significant progress has been achieved in the implementation of prevention and more effective treatment strategies and also better informed public health policies. However, the concept of addiction as a brain disease is still being questioned. This article presents arguments to consider substance use disorder as a disease caused by alterations in the structure and functioning of specific areas of the brain, as well as to visualize the clinical implications and the public policies of this disease model.

[Reliability and dimensionality of PHQ-9 in screening depression symptoms among health science students in Cartagena, 2014].

INTRODUCTION: Depression among university students must be screened with valid instruments. The Patient Health Questionnaire (PHQ-9) is reliable and valid for screening depression in a university context; however, its psychometric performance in Colombia is unknown. OBJECTIVE: To estimate the reliability and dimensionality of PHQ-9 as a screening instrument for depressive symptoms among health sciences students of a university in Cartagena, Colombia.Materials y methods: We analyzed the factorial structure and reliability of the PHQ-9 in a sample of 550 students for expected prevalence of clinically-meaningful depressive symptoms (CMDS) of 25% with a confidence level of 95% and an error level of 3%. We used the free Spanish version of PHQ-9 for Colombia, authorized by its creators. A confirmatory factorial analysis, and an estimate of internal consistency using Cronbach´s alfa and McDonald´s omega were obtained. RESULTS: We analyzed 541 surveys. The average age of the group was 20.18 (SD=2.59) years old, 354 (63.77%) participants were women and 196 (36.23%) men. CMDS prevalence was 27.3%. The confirmatory factorial analysis exhibited a two-factor model, which explained the total variance of 42.80%. The proportion of variance explained by the factors was 0.243 (item 5) and 0.587 (item 2). Cronbach´s alfa was 0.830 and McDonald´s omega, 0.89. CONCLUSIONS: PHQ-9 was a valid and reliable tool for screening depressive symptoms among health sciences students in a university in Cartagena, Colombia.